A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AIS

NCT04091945 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: LT3001 Drug Product
DRUG: Placebo

Sponsor

Lumosa Therapeutics Co., Ltd.